Back to search

Article

Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese Population

2021-05-05

Abstract excerpt

<h4>Background: </h4> Triple-negative breast cancer (TNBC) represents about 19% of all breast cancer cases in the Chinese population, and is characterized by early relapse and a complex molecular heterogeneity. Lack of targeted therapy contributes to the poorer outcomes compared with other breast cancer subtypes. Comprehensive genomic profiling helps to explore the clinically relevant genomic alterations (CRGAs) a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f17dbaf2-0c2a-55c4-b875-a6b539eb72d8
DOI
10.21203/rs.3.rs-466470/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationDOI 10.21203/rs.3.rs-466470/v1
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.Semantic proximity
Prevalent Landscape of Tumor Genomic Alterations of Luminal B1 Breast Cancers Using a Comprehensive Genomic Profiling Assay in TaiwanSemantic proximity
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsSemantic proximity
Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.Semantic proximity
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.Semantic proximity
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.Semantic proximity
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesSemantic proximity
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.Semantic proximity
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.Semantic proximity
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.Semantic proximity
Comprehensive Genomic Profiling of Taiwanese Breast Cancer Using a Novel Targeted Sequencing PanelSemantic proximity
Whole exome sequencing for identification of specific gene mutations in an Indian cohort of triple- negative breast cancer patientsSemantic proximity
Select a neighboring publication to make it the new centre.